Annual report pursuant to Section 13 and 15(d)

Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)

v3.3.1.900
Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2015
Notes Tables  
Schedule of Franchisor Disclosure [Table Text Block]
    Year Ended
 December 31,
Franchised clinics:   2015   2014
 Clinics open at beginning of period     242       175  
 Opened during the period     54       73  
 Acquired during the period     (24 )     (4 )
 Closed during the period     (7 )     (2 )
 Clinics in operation at the end of the period     265       242  
    Year Ended
 December 31,
Company-owned or managed clinics:   2015   2014
 Clinics open at beginning of period     4       -  
 Opened during the period     21       -  
 Acquired during the period     24       4  
 Closed during the period     (2 )     -  
 Clinics in operation at the end of the period     47       4  
                 
 Total clinics in operation at the end of the period     312       246  
                 
 Clinics licenses sold but not yet developed     168       268  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
    Year Ended
December 31,
    2015   2014
         
Net loss   $ (8,797,321 )   $ (3,031,220 )
                 
Weighted average common shares outstanding - basic     10,042,001       5,451,851  
Effect of dilutive securities:                
Stock options     -       -  
Weighted average common shares outstanding - diluted     10,042,001       5,451,851  
                 
Basic and diluted loss per share   $ (0.88 )   $ (0.56 )
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
    Year Ended
December 31,
    2015   2014
Unvested restricted stock     339,288       590,868  
Stock options     477,459       314,775  
Warrants     90,000       90,000